Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionSt Germain D J Co Inc
Latest Disclosed Ownership19,846 shares
Latest Disclosed Value $ 1,203,660
St Germain D J Co Inc reports 1.02% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 13, 2026 - St Germain D J Co Inc filed a 13F-HR form disclosing ownership of 19,846 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,040,327 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 19,646 shares of Bristol-Myers Squibb Company. This represents a change in shares of 1.02% during the quarter. The current value of the position is $941,296 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 19,846 200 1.02 1,204 13.60 0.0476
2026-01-29 2025-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 19,646 -750 -3.68 1,060 15.23 0.0412
2025-10-07 2025-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 20,396 -1,162 -5.39 920 -7.82 0.0368
2025-07-16 2025-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 21,558 1,303 6.43 998 -19.27 0.0430
2025-04-09 2025-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 20,255 110 0.55 1,235 8.43 0.0581
2025-01-10 2024-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 20,145 -2,601 -11.43 1,139 -3.15 0.0518
2024-10-18 2024-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 22,746 1,021 4.70 1,177 30.38 0.0541
2024-07-08 2024-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 21,725 -1,122 -4.91 902 -27.14 0.0437
2024-04-02 2024-03-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 22,847 -91 -0.40 1,239 5.27 0.0606
2024-01-02 2023-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 22,938 168 0.74 1,177 -10.98 0.0613
2023-10-23 2023-09-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 22,770 0 0.00 1,322 -9.27 0.0743
2023-09-07 2023-06-30 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 22,770 -11,443 -33.45 1,456 60.53 0.0769
2023-02-27 2022-12-31 13F BRISTOL-MYERS SQUIBB CO COM Stock 110122108 34,213 11,535 50.86 907 -48.05 0.3049
2022-11-21 2022-09-30 13F Bristol Myers Squibb COM 110122108 22,678 0 0.00 1,746 0.00 0.1153
2022-08-15 2022-06-30 13F/A-1 Bristol Myers Squibb COM 110122108 22,678 -215 -0.94 1,746 4.43 0.1153
2022-08-12 2022-06-30 13F Bristol Myers Squibb COM 110122108 22,893 0 1,672 0.0940
2022-05-12 2022-03-31 13F Bristol Myers Squibb COM 110122108 22,893 -350 -1.51 1,672 15.39 0.0940
2022-02-11 2021-12-31 13F Bristol Myers Squibb COM 110122108 23,243 426 1.87 1,449 7.33 0.0797
2021-11-03 2021-09-30 13F Bristol Myers Squibb COM 110122108 22,817 112 0.49 1,350 -11.01 0.0831
2021-07-28 2021-06-30 13F Bristol Myers Squibb COM 110122108 22,705 114 0.50 1,517 6.38 0.0952
2021-05-13 2021-03-31 13F Bristol Myers Squibb COM 110122108 22,591 10 0.04 1,426 1.78 0.0964
2021-02-04 2020-12-31 13F Bristol Myers Squibb COM 110122108 22,581 1,972 9.57 1,401 12.71 0.1000
2020-11-10 2020-09-30 13F Bristol Myers Squibb COM 110122108 20,609 -311 -1.49 1,243 1.06 0.1009
2020-08-13 2020-06-30 13F Bristol Myers Squibb COM 110122108 20,920 -1,115 -5.06 1,230 0.16 0.1077
2020-05-13 2020-03-31 13F Bristol Myers Squibb COM 110122108 22,035 1,121 5.36 1,228 -8.49 0.1207
2020-02-14 2019-12-31 13F Bristol Myers Squibb COM 110122108 20,914 12,415 146.08 1,342 211.37 0.1127
2019-10-17 2019-09-30 13F Bristol Myers Squibb COM 110122108 8,499 86 1.02 431 12.83 0.0464
2019-07-24 2019-06-30 13F Bristol Myers Squibb COM 110122108 8,413 0 0.00 382 -4.74 0.0416
2019-05-02 2019-03-31 13F Bristol Myers Squibb COM 110122108 8,413 -250 -2.89 401 -10.89 0.0437
2019-02-05 2018-12-31 13F Bristol Myers Squibb COM 110122108 8,663 2,180 33.63 450 11.94 0.0534
2018-10-23 2018-09-30 13F Bristol Myers Squibb COM 110122108 6,483 6,483 402 0.0450
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.